Naviter Wealth, LLC Amgen Inc Transaction History

Naviter Wealth, LLC

$814 Million
Q4 2024

A detailed history of Naviter Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Naviter Wealth, LLC holds 7,104 shares of AMGN stock, worth $2.19 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

7,104

Previous 5,313 33.71%

Holding current value

$2.19 Million

Previous $1.71 Million 8.18%

% of portfolio

0.23%

Previous 0.24%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	BUY	$258.78 - $328.31 $463,474 - $588,003	1,791 Added 33.71%	7,104 $1.85 Million
Q3 2024 Oct 16, 2024	SELL	$309.38 - $337.38 $47,025 - $51,281	-152 Reduced 2.78%	5,313 $1.71 Million
Q2 2024 Aug 01, 2024	BUY	$262.75 - $319.31 $135,316 - $164,444	515 Added 10.4%	5,465 $1.71 Million
Q1 2024 Apr 18, 2024	BUY	$268.87 - $324.56 $341,733 - $412,515	1,271 Added 34.55%	4,950 $1.41 Million
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $168,506 - $190,095	659 Added 21.82%	3,679 $1.06 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $61,877 - $76,823	283 Added 10.34%	3,020 $811,000
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $53,781 - $63,595	251 Added 10.1%	2,737 $607,000
Q1 2023 Apr 12, 2023	SELL	$225.79 - $275.2 $39,287 - $47,884	-174 Reduced 6.54%	2,486 $600,000
Q4 2022 Jan 31, 2023	BUY	$229.03 - $291.01 $59,547 - $75,662	260 Added 10.83%	2,660 $698,000
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $51,850 - $58,477	231 Added 10.65%	2,400 $541,000
Q2 2022 Jul 18, 2022	BUY	$230.71 - $256.74 $500,409 - $556,869	2,169 New	2,169 $528,000

Others Institutions Holding AMGN

# of Institutions

3,172

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Naviter Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Naviter Wealth, LLC with notifications on news.

Account

Naviter Wealth, LLC Amgen Inc Transaction History